The recent instability in global chains have highlighted the value of securing vital medications like Ivermectin. Relying on overseas manufacturers exposes regions to potential vulnerabilities, including delivery delays, expense fluctuations, and even political threats. Shifting towards domestic procurement of Ivermectin offers a multitude of advan